Trial Profile
An Efficacy and Safety Study of HCP1105 Capsule in Combined Hyperlipidemic Patients With High Risk for Coronary Heart Disease (CHD): A Randomized,Double-blind, Multicenter, Phase 3 Study
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs HCP 1105 (Primary) ; HGP 0816
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 22 Sep 2015 New trial record